Disease Overview：Testicular Cancer（TC）
Testicular cancer is a malignant neoplasm arising from germ cells of the testis, most commonly diagnosed in males aged 15–35 years. The majority—approximately 95%—are germ cell tumors, including seminomas and non-seminomatous germ cell tumors (NSGCTs) such as embryonal carcinoma, yolk sac tumor, choriocarcinoma, and teratoma. Early detection often reveals a painless testicular mass, with advanced disease potentially presenting with retroperitoneal lymphadenopathy, pulmonary metastases, or elevated serum tumor markers (AFP, β-hCG, LDH). Staging follows the AJCC TNM classification, guiding risk-stratified management: surveillance for stage I, adjuvant chemotherapy (e.g., single-agent carboplatin for stage I seminoma), or multi-agent regimens (e.g., bleomycin-etoposide-cisplatin) for higher-stage or NSGCT cases. With timely intervention, overall 5-year survival exceeds 95%, even in metastatic disease.
China offers compelling advantages for international patients seeking testicular cancer care. Leading oncology centers—such as Peking University Cancer Hospital and Fudan University Shanghai Cancer Center—employ multidisciplinary tumor boards, integrate PET-CT and MRI-based staging, and utilize precision oncology approaches including tumor marker monitoring and fertility-preserving strategies. Clinical outcomes align with global benchmarks: published data report >90% 5-year progression-free survival in stage II/III disease treated with cisplatin-based regimens. Advanced radiotherapy platforms (e.g., TrueBeam STx) enable highly conformal radiation for seminoma, minimizing gonadal and bowel exposure. Treatment costs are typically 40–60% lower than in the US or Western Europe without compromising evidence-based protocols or accreditation standards (JCI-certified hospitals available).
As a dedicated medical tourism agency, we facilitate seamless access to these high-caliber services: verifying physician credentials, coordinating appointments with urologic oncologists and medical oncologists, arranging pre-arrival diagnostics, providing transparent, all-inclusive pricing (covering consultations, surgery, chemotherapy cycles, imaging, and follow-up), and offering end-to-end support—from visa assistance and airport transfers to bilingual nursing liaison and accommodation.
Testicular Cancer: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Testicular Cancer (Oncology Department)
Non-Surgical / Medical Management
*Indicated for Stage I seminoma (adjuvant carboplatin), Stage II–III germ cell tumors (cisplatin-based chemotherapy), and metastatic disease.*
- •Chemotherapy (BEP regimen: Bleomycin, Etoposide, Cisplatin)
- *Cost per cycle:* $1,850–$2,300 (includes drugs, IV administration, nursing, monitoring) - *Total for 3–4 cycles:* $5,550–$9,200
- •Adjuvant Carboplatin (single-agent, Stage I seminoma)
- *Total (1–2 doses):* $420–$1,160
- •Supportive Care & Monitoring
- CT abdomen/pelvis (contrast-enhanced): $280–$360 - Chest X-ray: $25–$40 - Routine blood counts & renal/hepatic panels: $75–$110/session
Surgical / Interventional Options
*All procedures performed in Urology/Oncology surgical units.*
- •Radical Inguinal Orchiectomy (RIO)
- *Preoperative workup:* Scrotal ultrasound ($110–$150), CBC/coagulation panel ($55–$85), ECG ($30–$45) - *Procedure cost:* $2,100–$2,900 (including anesthesia, OR time, pathology grossing & sectioning)
- •Retroperitoneal Lymph Node Dissection (RPLND)
- *Cost:* $6,400–$8,700 (robot-assisted: +$1,200–$1,800) - *Pre-op:* PET/CT ($720–$950), pulmonary function tests ($90–$130)
Special/Complex Condition Management
- •Salvage Chemotherapy (e.g., TIP, VeIP regimens)
- •High-Dose Chemotherapy + Autologous Stem Cell Transplant (HDCT-ASCT)
- *Total cost:* $28,500–$36,000 (includes mobilization, apheresis, conditioning, transplant, 30-day inpatient care)
Quick Selection Guide
- •Young, low-risk Stage I seminoma (<40 y/o, no comorbidities): RIO + surveillance ($2,300 total) — *most cost-effective, preserves fertility/hormonal function.*
- •Stage II NSGCT, fit patient: RIO → BEP × 4 → RPLND if residual mass ($14,200–$19,800) — *curative-intent standard.*
- •Elderly (>65 y/o) or significant comorbidities (COPD, CKD): Carboplatin adjuvant (if seminoma) or reduced-dose BEP × 3 ($6,000–$8,500) — *balances efficacy with toxicity risk.*
- •Relapsed/refractory disease: HDCT-ASCT ($32,000 median) — *only curative option for salvage; requires multidisciplinary assessment.*
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Testicular Cancer Medical Vacation Packages
Curated transparent all-inclusive packages combining Testicular Cancer treatment with China top medical destinations:
